A patient has a C‑peptide level of 0.6 ng/mL and a concurrent blood glucose of 368 mg/dL—what is the most likely type of diabetes and how should it be managed?

Type 1 Diabetes with Severe Insulin Deficiency Requiring Immediate Insulin Therapy

A C-peptide of 0.6 ng/mL (approximately 200 pmol/L) in the setting of marked hyperglycemia (368 mg/dL) indicates type 1 diabetes with severe beta-cell dysfunction, and this patient requires immediate insulin therapy for survival. 1

Diagnostic Interpretation

• C-peptide values ≤200 pmol/L (≤0.6 ng/mL) are consistent with type 1 diabetes according to American Diabetes Association guidelines. 1, 2
• The concurrent blood glucose of 368 mg/dL with such a low C-peptide demonstrates absolute insulin deficiency—the pancreas cannot produce adequate insulin even in the face of severe hyperglycemia. 1
• This level falls at the critical threshold distinguishing type 1 from type 2 diabetes; values >600 pmol/L (>1.8 ng/mL) would indicate type 2 diabetes with preserved beta-cell function. 2

Confirm the Diagnosis

• Check islet autoantibodies (GAD, IA-2, ZnT8) to confirm autoimmune type 1 diabetes. 2
• If antibody-positive, the diagnosis of type 1 diabetes is definitive regardless of other factors. 2
• Approximately 5-10% of adults with type 1 diabetes are antibody-negative, making the low C-peptide measurement essential for classification in this subset. 2
• Consider maturity-onset diabetes of the young (MODY) only if the patient is under 35 years, has HbA1c <7.5% at diagnosis, has a parent with diabetes, and lacks features of autoimmune disease—though the severe hyperglycemia here makes MODY unlikely. 2

Immediate Management Algorithm

• Initiate basal-bolus insulin therapy immediately because C-peptide <200 pmol/L indicates absolute insulin deficiency and the patient requires insulin for survival. 1
• Do not attempt oral antihyperglycemic agents or insulin-sensitizing medications (metformin, thiazolidinediones), as these require residual beta-cell function to be effective. 3
• Assess for diabetic ketoacidosis (DKA) given the severe hyperglycemia—check serum ketones, bicarbonate, and anion gap, as DKA can be the first presentation of type 1 diabetes with low C-peptide levels. 1

Critical Testing Considerations

• The C-peptide result is reliable because the concurrent glucose is markedly elevated (368 mg/dL), well above the threshold where hypoglycemia might confound interpretation. 1
• Do not repeat C-peptide testing if the initial value is very low (<80 pmol/L or <0.24 ng/mL), as this definitively indicates severe insulin deficiency. 1, 2
• If this measurement was taken within 2 weeks of a hyperglycemic emergency (DKA), consider repeating after stabilization, though the clinical picture already mandates insulin therapy. 1

Long-Term Management Implications

• Patients with C-peptide <0.2 nmol/L (approximately <0.6 ng/mL) are at higher risk for severe hypoglycemia and diabetic ketoacidosis due to complete loss of endogenous insulin secretion and absent counterregulatory glucagon response. 4, 5
• Target HbA1c <7.0% to reduce microvascular complications, though individualized targets may be appropriate based on hypoglycemia risk. 3
• The absence of measurable C-peptide does not predict response to intensive insulin therapy; treatment intensity should be guided by glycemic control, not C-peptide levels. 1
• Consider continuous glucose monitoring and insulin pump therapy to optimize glycemic control and reduce acute complication risk in this patient with absolute insulin deficiency. 1

Common Pitfalls to Avoid

• Do not misclassify this patient as type 2 diabetes based on age, BMI, or phenotype alone—approximately 40% of adults with new type 1 diabetes are initially misdiagnosed as type 2. 2
• Do not delay insulin initiation while awaiting autoantibody results; the low C-peptide with severe hyperglycemia mandates immediate treatment. 1
• Do not use C-peptide levels as a prerequisite for insulin-pump eligibility or to justify insulin therapy to payers—clinical insulin deficiency is sufficient indication. 1